Literature DB >> 11103928

Definition, interpretation and calculation of cost-effectiveness acceptability curves.

M Löthgren1, N Zethraeus.   

Abstract

This paper discusses the definition, interpretation and computation of cost-effectiveness (CE) acceptability curves. A formal definition of the CE acceptability curve based on the net benefit approach is provided. The curve can be computed using parametric or non-parametric techniques and for both computational approaches we establish a formal relation between the CE acceptability curve and statistical inference based on confidence intervals and P values in CE analysis.

Mesh：

Year:  2000        PMID： 11103928     DOI： 10.1002/1099-1050(200010)9:7<623::aid-hec539>3.0.co;2-v

Source DB:  PubMed          Journal:  Health Econ        ISSN： 1057-9230            Impact factor:   3.046


  76 in total

Review 1.  Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.

Authors:  Niklas Zethraeus; Magnus Johannesson; Bengt Jönsson; Mickael Löthgren; Magnus Tambour
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

3.  Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs.

Authors:  Todd A Olmstead; Jody L Sindelar; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2006-09-12       Impact factor: 4.492

Review 4.  Health economic evaluation in lumbar spinal fusion: a systematic literature review anno 2005.

Authors:  Rikke Soegaard; Finn B Christensen
Journal:  Eur Spine J       Date:  2005-12-21       Impact factor: 3.134

5.  Pricing matrix model: dealing with uncertainty.

Authors:  Mark J C Nuijten
Journal:  Eur J Health Econ       Date:  2007-01-13

6.  Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

7.  Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach.

Authors:  Annemieke De Ridder; Diana De Graeve
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor-and HER2-Positive Metastatic Breast Cancer.

Authors:  Thomas E Delea; Carol Hawkes; Mayur M Amonkar; Konstantinos Lykopoulos; Stephen R D Johnston
Journal:  Breast Care (Basel)       Date:  2013-12       Impact factor: 2.860

9.  Pelvic floor consequences of cesarean delivery on maternal request in women with a single birth: a cost-effectiveness analysis.

Authors:  Xiao Xu; Julie S Ivy; Divya A Patel; Sejal N Patel; Dean G Smith; Scott B Ransom; Dee Fenner; John O L Delancey
Journal:  J Womens Health (Larchmt)       Date:  2010-01       Impact factor: 2.681

Review 10.  Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.

Authors:  Marian A Spath; Bernie J O'Brien
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.